Cite
HARVARD Citation
Büscheck, F. et al. (2019). The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer. Tumor biology. 41 (7), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Büscheck, F. et al. (2019). The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer. Tumor biology. 41 (7), p. . [Online].